The hu14.18-IL-2 immunocytokine containing a humanized anti-GD2 mAb linked to IL-2 was mainly studied as mono-therapy in neuroblastoma and in combination with anti-CTLA-4 plus RT in primary and metastatic melanoma. The gene discussed is IL2; the disease is metastatic melanoma.